Log in
(Ad)
In early 2019 President Trump warned this company's biggest customers to "step up their 5G efforts." A few months later, he banned their biggest competitor from doing business in the U.S. Now, this $5 stock could turn a $10,000 stake into $234,770 this year. But timing is critical. A single mention on the evening news and this opportunity could get away from you.

NASDAQ:GMDA - Gamida Cell Stock Price, Forecast & News

$4.64
0.00 (0.00 %)
(As of 01/23/2020 08:47 AM ET)
Today's Range
$4.40
Now: $4.64
$4.65
50-Day Range
$4.30
MA: $4.64
$5.10
52-Week Range
$2.93
Now: $4.64
$15.00
Volume14,745 shs
Average Volume30,189 shs
Market Capitalization$112.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.64
Gamida Cell Ltd. is a clinical stage biopharmaceutical company, which engages in the development of cell therapies that are designed to cure cancer and rare serious hematologic diseases. Its products pipeline include NiCord and NAM-NK. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel.

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GMDA
CUSIPN/A
CIKN/A
Phone972-2659-5666

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$1.02 per share

Profitability

Net Income$-52,930,000.00

Miscellaneous

Employees70
Market Cap$112.38 million
Next Earnings Date2/24/2020 (Estimated)
OptionableNot Optionable

Receive GMDA News and Ratings via Email

Sign-up to receive the latest news and ratings for GMDA and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

Join a small community of investors looking for the next big winner. Every Sunday reveals 3 compelling stocks that should be on your radar for the week ahead. Sign up here to see what stocks have made it to our watchlist this week.

Gamida Cell (NASDAQ:GMDA) Frequently Asked Questions

What is Gamida Cell's stock symbol?

Gamida Cell trades on the NASDAQ under the ticker symbol "GMDA."

How were Gamida Cell's earnings last quarter?

Gamida Cell Ltd (NASDAQ:GMDA) issued its earnings results on Wednesday, November, 13th. The company reported ($0.30) earnings per share for the quarter, topping the consensus estimate of ($0.37) by $0.07. View Gamida Cell's Earnings History.

When is Gamida Cell's next earnings date?

Gamida Cell is scheduled to release their next quarterly earnings announcement on Monday, February 24th 2020. View Earnings Estimates for Gamida Cell.

What price target have analysts set for GMDA?

3 brokers have issued twelve-month price objectives for Gamida Cell's shares. Their forecasts range from $16.00 to $19.00. On average, they expect Gamida Cell's share price to reach $17.67 in the next year. This suggests a possible upside of 280.7% from the stock's current price. View Analyst Price Targets for Gamida Cell.

What is the consensus analysts' recommendation for Gamida Cell?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Gamida Cell in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Gamida Cell.

Has Gamida Cell been receiving favorable news coverage?

Media headlines about GMDA stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Gamida Cell earned a media sentiment score of 1.6 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Gamida Cell.

Are investors shorting Gamida Cell?

Gamida Cell saw a drop in short interest in the month of December. As of December 31st, there was short interest totalling 1,200 shares, a drop of 84.0% from the December 15th total of 7,500 shares. Based on an average daily trading volume, of 36,900 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the shares of the stock are sold short. View Gamida Cell's Current Options Chain.

Who are some of Gamida Cell's key competitors?

What other stocks do shareholders of Gamida Cell own?

Who are Gamida Cell's key executives?

Gamida Cell's management team includes the folowing people:
  • Julian Adams, Chief Executive Officer & Director
  • Yael Margolin, President
  • Tzvi Palash, Chief Operating Officer
  • Shai Lankry, Chief Financial & Accounting Officer
  • Tony Peled, Chief Scientific Officer, Vice President-R&D

When did Gamida Cell IPO?

(GMDA) raised $50 million in an initial public offering on Friday, October 26th 2018. The company issued 3,600,000 shares at a price of $13.00-$15.00 per share. BMO Capital Markets and RBC Capital Markets acted as the underwriters for the IPO and Needham & Company Oppenheimer & Co. was co-manager.

How do I buy shares of Gamida Cell?

Shares of GMDA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Gamida Cell's stock price today?

One share of GMDA stock can currently be purchased for approximately $4.64.

How big of a company is Gamida Cell?

Gamida Cell has a market capitalization of $112.38 million. The company earns $-52,930,000.00 in net income (profit) each year or ($10.53) on an earnings per share basis. Gamida Cell employs 70 workers across the globe.View Additional Information About Gamida Cell.

What is Gamida Cell's official website?

The official website for Gamida Cell is http://www.gamida-cell.com/.

How can I contact Gamida Cell?

Gamida Cell's mailing address is 5 NAHUM HAFZADI STREET GIVAAT SHAUL, JERUSALEM L3, 91340. The company can be reached via phone at 972-2659-5666 or via email at [email protected]


MarketBeat Community Rating for Gamida Cell (NASDAQ GMDA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  62 (Vote Outperform)
Underperform Votes:  62 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about Gamida Cell and other stocks. Vote "Outperform" if you believe GMDA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GMDA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel